 |
|
Nebulized Budesonide and Oral Dexamethasone for Treatment of Croup
A Randomized Controlled Trial
Terry P. Klassen, MD;
William R. Craig, MD, CM;
David Moher, MSc;
Martin H. Osmond, MD, CM;
Hans Pasterkamp, MD;
Terry Sutcliffe, BA;
Lise K. Watters, MD;
Peter C. Rowe, MD
JAMA. 1998;279:1629-1632.
Context.— The effectiveness of glucocorticoids for patients with croup is well established but it remains uncertain which glucocorticoid regimen is most effective.
Objective.— To determine the effectiveness of 3 glucocorticoid regimens in patients with croup.
Design.— Randomized controlled trial with parallel design.
Setting.— Emergency departments of 2 Canadian pediatric tertiary care hospitals.
Participants.— Children with a clinical syndrome consistent with croup, aged 3 months to 5 years, with a croup score of 2 or greater following at least 15 minutes of mist therapy.
Interventions.— Oral dexamethasone, 0.6 mg/kg, and nebulized placebo; oral placebo and nebulized budesonide, 2 mg; or oral dexamethasone, 0.6 mg/kg, and nebulized budesonide, 2 mg.
Main Outcome Measures.— Westley croup score (primary outcome), hospital admission rates, time spent in the emergency department, return visits to the emergency department, or ongoing symptoms at 1 week.
Results.— The mean change in the croup score from baseline to the final study assessment was -2.3 (95% confidence interval [CI], -2.6 to -2.0) in the budesonide group (n=65), -2.4 (95% CI, -2.6 to -2.2) in the dexamethasone group (n=69), and -2.4 (95% CI, -2.7 to -2.1) in the budesonide and dexamethasone group (n=64, P=.70).
Conclusions.— Based on the similar outcomes in the 3 groups, oral dexamethasone is the preferred intervention because of its ease of administration, lower cost, and more widespread availability.
From the Departments of Pediatrics (Drs Klassen, Osmond, and Watters, Ms Moher, and Mr Sutcliffe), and Epidemiology and Community Medicine (Dr Klassen and Mr Moher), University of Ottawa, Ottawa, Ontario; the Department of Child Health, University of Manitoba, Winnipeg (Drs Craig and Pasterkamp); and the Department of Pediatrics, Johns Hopkins University, Baltimore, Md (Dr Rowe).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Use of helium-oxygen mixtures in the treatment of croup: a systematic review
Vorwerk and Coats
Emerg. Med. J. 2008;25:547-550.
ABSTRACT
| FULL TEXT
Humidified air inhalation for treating croup: a systematic review and meta-analysis
Moore and Little
Fam Pract 2007;24:295-301.
ABSTRACT
| FULL TEXT
A Multicenter, Randomized, Controlled Trial of Dexamethasone for Bronchiolitis
Corneli et al.
NEJM 2007;357:331-339.
ABSTRACT
| FULL TEXT
Changing Epidemiology of Life-Threatening Upper Airway Infections: The Reemergence of Bacterial Tracheitis
Hopkins et al.
Pediatrics 2006;118:1418-1421.
ABSTRACT
| FULL TEXT
Controlled Delivery of High vs Low Humidity vs Mist Therapy for Croup in Emergency Departments: A Randomized Controlled Trial
Scolnik et al.
JAMA 2006;295:1274-1280.
ABSTRACT
| FULL TEXT
Oral Dexamethasone for Mild Croup
Vernacchio et al.
NEJM 2004;351:2768-2769.
FULL TEXT
Animal Pneumoviruses: Molecular Genetics and Pathogenesis
Easton et al.
Clin. Microbiol. Rev. 2004;17:390-412.
ABSTRACT
| FULL TEXT
The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management
Anaissie et al.
Blood 2004;103:1611-1617.
ABSTRACT
| FULL TEXT
The management of croup
Brown
Br Med Bull 2002;61:189-202.
ABSTRACT
| FULL TEXT
Corticosteroids for croup
DTB 2000;38:22-24.
ABSTRACT
| FULL TEXT
The Treatment of Croup with Glucocorticoids
Jaffe
NEJM 1998;339:553-555.
FULL TEXT
Oral Dexamethasone Preferred for Mild to Moderate Croup
JWatch Emergency Med. 1998;1998:4-4.
FULL TEXT
Outpatient Croup Treatments Compared
JWatch General 1998;1998:8-8.
FULL TEXT
|
